A New Powerhouse in Life Sciences: Argano's Big Move

Argano, a global consultancy known for its AI-driven approach to business transformation, has made a significant move. They've acquired Pharosity Consulting, a firm that specializes in helping pharmaceutical and biotech companies navigate complex regulations and data. This is Argano's eighth deal since they launched their growth program in April 2025, and their 24th since starting in 2020. Pharosity, founded in 2015, brings something unique to the table. They're experts in areas like Gross-to-Net (GTN), government pricing, and commercial contracting. Their structured approach helps clients handle complex regulations and commercial functions efficiently. This acquisition is a big deal because it strengthens Argano's ability to help clients modernize their finance, revenue, and analytics operations. Chip Register, Argano's Group CEO, is excited about this move. He believes Pharosity's expertise complements Argano's platform well. Together, they aim to deliver AI-enabled high-performance operations for pharmaceutical organizations facing complex regulatory and data environments.Pharosity's services also complement those of Twelve Consulting Group, which joined Argano in 2025. Together, they offer a comprehensive solution that includes strategic advisory, advanced analytics, and enterprise technology. This is great news for pharmaceutical, medical device, and diagnostic companies. It means they can optimize their core operating models and engage more effectively with regulators. Brian Barbash, Co-Founder of Pharosity, is also thrilled about this partnership. He believes joining Argano will help them extend their reach and deliver even more value to their clients. The transaction closed in December 2025, with several firms providing legal and financial advisory services. Argano is known for its focus on high-performance business operations. They use an AI-forward approach to help clients drive efficiency and agility. Their services span customer engagement, revenue management, finance and planning, supply chain, and workforce optimization. They're all about competitive advantage, cost optimization, customer satisfaction, and sustainable growth. Pharosity, on the other hand, is all about helping life sciences companies navigate regulatory complexity. They use data-informed strategies to drive performance and operational execution. Together, Argano and Pharosity are set to make a big impact in the life sciences industry.